Ani Pharmaceuticals ANIP
NASDAQ ANIP
$72.96 +0.31 (+0.43%)
At close: Oct 1, 2026 · 4:00 PM EDT

Ani Pharmaceuticals (ANIP) Current Deferred Tax Assets (2014 - 2015)

Updated

Ani Pharmaceuticals (ANIP) posted Current Deferred Tax Assets of $8.27 million for Q3 2015, up 3.3% from the prior quarter.

Analysis

Ani Pharmaceuticals (ANIP) Current Deferred Tax Assets (2014 - 2015) Analysis & Trends

At the end of FY2014, Ani Pharmaceuticals' Current Deferred Tax Assets came in at $7.64 million.

  • According to Business Quant data, Current Deferred Tax Assets for the three prior quarters was $8 million (Q2 2015), $7.78 million (Q1 2015) and $7.64 million (Q4 2014).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Ani Pharmaceuticals 1.73 Bn 513.34 Mn 165.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 8.27 Mn
Jun 30, 2015 8.00 Mn
Mar 31, 2015 7.78 Mn
Dec 31, 2014 7.64 Mn
API Access

Ani Pharmaceuticals Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=ANIP&period=max&api_key=YOUR_API_KEY